These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 34519052)

  • 1. From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders.
    Kozlowska U; Nichols C; Wiatr K; Figiel M
    J Neurochem; 2022 Jul; 162(1):89-108. PubMed ID: 34519052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.
    Mertens LJ; Preller KH
    Pharmacopsychiatry; 2021 Jul; 54(4):176-190. PubMed ID: 33472250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of psychedelics in psychiatry, a systematic review of the literature].
    Berkovitch L; Roméo B; Karila L; Gaillard R; Benyamina A
    Encephale; 2021 Aug; 47(4):376-387. PubMed ID: 33888297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychedelic-inspired approaches for treating neurodegenerative disorders.
    Saeger HN; Olson DE
    J Neurochem; 2022 Jul; 162(1):109-127. PubMed ID: 34816433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards an understanding of psychedelic-induced neuroplasticity.
    Calder AE; Hasler G
    Neuropsychopharmacology; 2023 Jan; 48(1):104-112. PubMed ID: 36123427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychedelics: Threshold of a Therapeutic Revolution.
    Heal DJ; Smith SL; Belouin SJ; Henningfield JE
    Neuropharmacology; 2023 Sep; 236():109610. PubMed ID: 37247807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychedelic drugs for psychiatric disorders.
    da Costa SC; Oesterle T; Rummans TA; Richelson E; Gold M
    J Neurol Sci; 2022 Sep; 440():120332. PubMed ID: 35841696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Contribution of serotonin 5-HT
    Ibi D
    Nihon Yakurigaku Zasshi; 2023 May; 158(3):229-232. PubMed ID: 36990794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical psychedelics in psychiatry - renaissance of interest and therapeutic perspectives.
    Jachimowski A; Kucia K
    Psychiatr Pol; 2023 Jun; 57(3):657-670. PubMed ID: 38043078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving cognitive functioning in major depressive disorder with psychedelics: A dimensional approach.
    Magaraggia I; Kuiperes Z; Schreiber R
    Neurobiol Learn Mem; 2021 Sep; 183():107467. PubMed ID: 34048913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.
    Haniff ZR; Bocharova M; Mantingh T; Rucker JJ; Velayudhan L; Taylor DM; Young AH; Aarsland D; Vernon AC; Thuret S
    Pharmacol Ther; 2024 Jun; 258():108641. PubMed ID: 38583670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. At the Forefront: Social Workers' Role in Psilocybin Treatment for Depression and Substance Misuse.
    Parker C; Wood BM
    Soc Work; 2024 Jun; 69(3):297-302. PubMed ID: 38697188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.
    Sousa TR; Rema J; Machado S; Novais F
    Curr Top Med Chem; 2022; 22(15):1250-1260. PubMed ID: 34852736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychedelic Medicines in Major Depression: Progress and Future Challenges.
    Bouso JC; Ona G; Dos Santos RG; Hallak JEC
    Adv Exp Med Biol; 2021; 1305():515-533. PubMed ID: 33834416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.
    Barnett BS; Greer GR
    J Acad Consult Liaison Psychiatry; 2021; 62(4):460-471. PubMed ID: 34210406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms.
    Skosnik PD; Sloshower J; Safi-Aghdam H; Pathania S; Syed S; Pittman B; D'Souza DC
    J Psychopharmacol; 2023 Jul; 37(7):687-697. PubMed ID: 37392016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psilocybin: A brief overview for psychiatric mental health nurse practitioners.
    Fradkin D
    Perspect Psychiatr Care; 2022 Jul; 58(3):1200-1203. PubMed ID: 34101846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychedelic renaissance: the next trip for psychiatry?
    Kelly JR; Baker A; Babiker M; Burke L; Brennan C; O'Keane V
    Ir J Psychol Med; 2022 Dec; 39(4):335-339. PubMed ID: 31543078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.